Legal Representation
Attorney
Howard I. Sobelman
USPTO Deadlines
Application History
25 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 14, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Feb 14, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Feb 14, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
Feb 13, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
Feb 13, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 13, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 10, 2025 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Feb 3, 2025 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
Feb 3, 2025 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
Feb 3, 2025 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
Jan 31, 2025 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
May 17, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
May 17, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
May 17, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
May 17, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
May 17, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
May 17, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
May 17, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Apr 17, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 5, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Apr 5, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Apr 5, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 23, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jul 28, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Platform as a service (PAAS) featuring software for administering the out-licensing of small molecules for use in cell and gene therapy to process cell expansion, rejuvenation and engineering
Classification
International Classes
042